Octapharma GmbH is one of the largest global healthcare companies in family ownership. Since 1983, the company has been developing medicines based on human plasma and cell lines at its headquarters in Switzerland. With a focus on hemophilia, immunology, and intensive care medicine, Octapharma supplies patients in over 120 countries with the goal of sustainably improving lives through modern therapies.